At the Clinical Center of Vojvodina, the first in vivo treatment on the Amplya device in Serbia was successfully conducted immediately after the completion of training. The professional and technical training of medical staff to operate the Amplya device was held in the Intensive Care Unit of the Clinic for Anesthesia from September 25 to October 12, 2023 by experts from Marlo Medic, one of the companies within the Marlo family.

Amplya is the most advanced continuous renal replacement therapy (CRRT) device manufactured by Bellco (Medtronic), which the Clinical Center of Vojvodina received as part of a donation from the United Arab Emirates to the Ministry of Health of the Republic of Serbia, consisting of eight units.

The company Marlo Medic, as a distributor of Medtronic, proudly supported this initiative by providing professional and technical support to the medical staff, with the assistance of Associate Professor Radmila Popović, PhD, Nada Anđelić, MD, PhD, and Chief Nursing Officer Violeta Kuzmanović.